Regulators in the US have approved the first official trial for the use of human embryonic stem cells in patients.
Science correspondent Tom Feilden explains the potential of stem-cell treatments.
And professor of regenerative medicine Chris Mason outlines the importance of these trials.
Get in touch with Today via
or text us on 84844.